Feasibility of buprenorphine maintenance therapy programs in the Ukraine: first promising treatment outcomes.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 19420948)

Published in Eur Addict Res on May 07, 2009

Authors

Michael Schaub1, Emilis Subata, Victor Chtenguelov, Gundo Weiler, Ambros Uchtenhagen

Author Affiliations

1: Research Institute for Public Health and Addiction, Zurich, Switzerland. michael.schaub@isgf.uzh.ch

Articles by these authors

Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction (2008) 3.01

Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health (2002) 1.89

Outpatient methadone maintenance treatment program. Quality of life and health of opioid-dependent persons in Lithuania. Medicina (Kaunas) (2007) 1.17

The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realities. Curr Opin HIV AIDS (2013) 1.14

Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine. Int J Drug Policy (2009) 1.11

Mortality in heroin-assisted treatment in Switzerland 1994-2000. Drug Alcohol Depend (2005) 1.08

Substance use problems in developing countries. Bull World Health Organ (2004) 1.03

Decreasing intravenous cocaine use in opiate users treated with prescribed heroin. Soz Praventivmed (2002) 1.02

Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up. Eur Addict Res (2003) 0.98

The impact and cost of the 2013 WHO recommendations on eligibility for antiretroviral therapy. AIDS (2014) 0.95

The relationship between legal status, perceived pressure and motivation in treatment for drug dependence: results from a European study of Quasi-Compulsory Treatment. Eur Addict Res (2006) 0.92

Snow control - an RCT protocol for a web-based self-help therapy to reduce cocaine consumption in problematic cocaine users. BMC Psychiatry (2011) 0.88

A prospective cohort study on orally administered heroin substitution for severely addicted opioid users. Addiction (2006) 0.84

Drug addiction maintenance treatment and quality of life measurements. Medicina (Kaunas) (2004) 0.84

Building a European consensus on minimum quality standards for drug treatment, rehabilitation and harm reduction. Eur Addict Res (2013) 0.82

A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals. Addiction (2011) 0.82

Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002. Eur J Epidemiol (2006) 0.81

Quasi-compulsory treatment of drug dependent offenders: an international literature review. Subst Use Misuse (2005) 0.81

Predictors of retention in the 'voluntary' and 'quasi-compulsory' treatment of substance dependence in europe. Eur Addict Res (2011) 0.79

Modes and impact of coercive inpatient treatment for drug-related conditions in Switzerland. Eur Addict Res (2002) 0.79

Comparing outcomes of 'voluntary' and 'quasi-compulsory' treatment of substance dependence in Europe. Eur Addict Res (2009) 0.79

Detection and treatment of HIV and hepatitis virus infections in Swiss correctional facilities. Int J Public Health (2008) 0.78

[Economic efficiency of methadone maintenance and factors affecting it]. Medicina (Kaunas) (2004) 0.78

Conversation with Ambros Uchtenhagen. Addiction (2003) 0.75

[Prognostic factors from a long-term follow-up of heroin-assisted treatment in Switzerland 1994-2007]. Psychiatr Prax (2010) 0.75

Compulsory treatment - what do we know and where should we go? Eur Addict Res (2002) 0.75

Understanding Swiss drug policy change and the introduction of heroin maintenance treatment. Eur Addict Res (2014) 0.75

The role of coalitions in drug policy. Some theoretical and observational considerations. Adicciones (2011) 0.75

The beginning of a new era. Eur Addict Res (2007) 0.75

Development of a monitoring system for heroin-assisted substitution treatment in Switzerland. Soz Praventivmed (2002) 0.75

Long-term follow-up of orally administered diacetylmorphine substitution treatment. Eur Addict Res (2010) 0.75

Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection. Eur Addict Res (2015) 0.75